Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2 - PubMed (original) (raw)
. 1997 Jun 13;272(24):15496-500.
doi: 10.1074/jbc.272.24.15496.
Affiliations
- PMID: 9182583
- DOI: 10.1074/jbc.272.24.15496
Free article
Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2
H F Bigg et al. J Biol Chem. 1997.
Free article
Abstract
The binding properties of the newly described tissue inhibitor of metalloproteinases-4 (TIMP-4) to progelatinase A and to the COOH-terminal hemopexin-like domain (C domain) of the enzyme were examined. We present evidence for the first time of a specific, high affinity interaction between TIMP-4 and the C domain of human gelatinase A and show that TIMP-4 binds both progelatinase A and the C domain in a similar manner to that of TIMP-2. Saturable binding of recombinant C domain to TIMP-4 and to TIMP-2 but not to TIMP-1 was demonstrated using a microwell protein binding assay. The recombinant collagen binding domain of gelatinase A, comprised of the three fibronectin type II-like repeats, did not bind to TIMP-4, indicating that binding is mediated selectively by the C domain. Binding to TIMP-4 was of high affinity with an apparent Kd of 1.7 x 10(-7) M but slightly weaker than that to TIMP-2 (apparent Kd of 0.66 x 10(-7) M). Affinity chromatography confirmed the TIMP-4-C domain interaction and also showed that the complex could not be disrupted by 1 M NaCl or 10% dimethyl sulfoxide, thereby further demonstrating the tight binding. To verify the biological significance of this interaction, binding of full-length progelatinase A to TIMP-4 was investigated. TIMP-4 and TIMP-2 but not TIMP-1 bound specifically to purified TIMP-2-free human recombinant full-length progelatinase A and to full-length rat proenzyme from the conditioned culture medium of ROS 17/2.8 cells. Preincubation of the C domain with TIMP-2 was found to reduce subsequent binding to TIMP-4 in a concentration-dependent manner. Competition between TIMP-2 and TIMP-4 for a common or overlapping binding sites on the gelatinase A C domain may occur; alternatively TIMP-2 may prevent the binding of TIMP-4 by steric hindrance or induction of a conformational change in the C domain. We propose that the binding of progelatinase A to TIMP-4 represents a third TIMP-progelatinase interaction in addition to that of progelatinase A with TIMP-2 and progelatinase B with TIMP-1 described previously. This new phenomenon may be of important physiological significance in modulating the cell surface activation of progelatinase A.
Similar articles
- Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
Fujimoto N, Ward RV, Shinya T, Iwata K, Yamashita K, Hayakawa T. Fujimoto N, et al. Biochem J. 1996 Feb 1;313 ( Pt 3)(Pt 3):827-33. doi: 10.1042/bj3130827. Biochem J. 1996. PMID: 8611162 Free PMC article. - Cell surface activation of progelatinase A (proMMP-2) and cell migration.
Nagase H. Nagase H. Cell Res. 1998 Sep;8(3):179-86. doi: 10.1038/cr.1998.18. Cell Res. 1998. PMID: 9791731 Review.
Cited by
- Remodeling of the left atrium in pacing-induced atrial cardiomyopathy.
Hoit BD, Takeishi Y, Cox MJ, Gabel M, Kirkpatrick D, Walsh RA, Tyagi SC. Hoit BD, et al. Mol Cell Biochem. 2002 Sep;238(1-2):145-50. doi: 10.1023/a:1019988024077. Mol Cell Biochem. 2002. PMID: 12349902 - Kinetic analysis of the binding of hemopexin-like domain of gelatinase B cloned and expressed in Pichia pastoris to tissue inhibitor of metalloproteinases-1.
Stute J, Pourmotabbed T, Tschesche H. Stute J, et al. J Protein Chem. 2003 Aug;22(6):509-14. doi: 10.1023/b:jopc.0000005499.51466.50. J Protein Chem. 2003. PMID: 14703983 - Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.
Spinale FG, Villarreal F. Spinale FG, et al. Biochem Pharmacol. 2014 Jul 1;90(1):7-15. doi: 10.1016/j.bcp.2014.04.011. Epub 2014 Apr 26. Biochem Pharmacol. 2014. PMID: 24780447 Free PMC article. Review. - MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.
Kuliczkowski W, Radomski M, Gąsior M, Urbaniak J, Kaczmarski J, Mysiak A, Negrusz-Kawecka M, Bil-Lula I. Kuliczkowski W, et al. Biomed Res Int. 2017;2017:9352015. doi: 10.1155/2017/9352015. Epub 2017 Jul 10. Biomed Res Int. 2017. PMID: 28770228 Free PMC article. - Circulating Tissue Inhibitor of Metalloproteinase-4 levels are not a Predictor of Preeclampsia in the period between 20 and 25 Weeks of Gestation.
Sandrim VC, Machado J, Bettiol H, Barbieri MA, Cardoso VC, Palei AC, Cavalli RC. Sandrim VC, et al. Rev Bras Ginecol Obstet. 2018 Dec;40(12):757-762. doi: 10.1055/s-0038-1676056. Epub 2018 Dec 7. Rev Bras Ginecol Obstet. 2018. PMID: 30536270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous